Home Access HIV test lacks proper package warnings, Confide inventor contends.
This article was originally published in The Tan Sheet
Executive Summary
HOME ACCESS HIV TEST KIT LACKS MANY OUTSIDE PACKAGE WARNINGS that FDA required of the Confide diagnostic HIV blood test formerly marketed by J&J, Elliot Millenson, the inventor of Confide, contends in a Sept. 8 letter to FDA that follows up on a Feb. 27 citizen petition. With regard to the purported lack of adequate outside warnings on Hoffman Estates, Ill.-based Home Access' blood test for HIV-1, Millenson, of Far Hills, N.J., says there are "no warnings about use by people with clotting disorders, no age use recommendations and no indication the [Home Access] kit is intended for self use."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: